Saturday 15 May 2010

Nitrofurantoina Macro




Nitrofurantoina Macro may be available in the countries listed below.


Ingredient matches for Nitrofurantoina Macro



Nitrofurantoin

Nitrofurantoin is reported as an ingredient of Nitrofurantoina Macro in the following countries:


  • Chile

International Drug Name Search

Thursday 13 May 2010

Paroxetina Uxa




Paroxetina Uxa may be available in the countries listed below.


Ingredient matches for Paroxetina Uxa



Paroxetine

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Paroxetina Uxa in the following countries:


  • Spain

International Drug Name Search

Tuesday 11 May 2010

Deferiprone


Pronunciation: de-FER-i-prone
Generic Name: Deferiprone
Brand Name: Ferriprox

Deferiprone may cause low white blood cell levels, which can lead to serious and possibly fatal infections. White blood cell counts will be performed before starting Deferiprone and while you take it. Be sure to keep all doctor and lab appointments. Contact your doctor right away if you experience symptoms of infection (eg, fever, chills, persistent sore throat or cough, flu-like symptoms, difficult or painful urination).





Deferiprone is used for:

Treating high levels of iron in the blood caused by blood transfusions in certain patients with the blood disease thalassemia.


Deferiprone is an iron-chelating agent. It works by binding to the extra iron in the blood and removing it from the body.


Do NOT use Deferiprone if:


  • you are allergic to any ingredient in Deferiprone

Contact your doctor or health care provider right away if any of these apply to you.



Before using Deferiprone:


Some medical conditions may interact with Deferiprone. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are able to become pregnant

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of irregular heartbeat (eg, QT prolongation) or other heart problems (eg, enlarged heart, heart failure, slow heartbeat), low blood potassium or magnesium levels, kidney or liver problems, or low white blood cell counts

  • if you have another type of anemia

Some MEDICINES MAY INTERACT with Deferiprone. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Other iron-chelating medicines (eg, deferoxamine) or milk thistle because they may increase the risk of Deferiprone's side effects

  • Diuretics (eg, furosemide, hydrochlorothiazide) or any medicine that may increase the risk of a certain type of irregular heartbeat (prolonged QT interval). Check with your doctor or pharmacist if you are unsure if any of your medicines may increase the risk of this type of irregular heartbeat

This may not be a complete list of all interactions that may occur. Ask your health care provider if Deferiprone may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Deferiprone:


Use Deferiprone as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Deferiprone comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Deferiprone refilled.

  • Take Deferiprone by mouth with or without food, as directed by your doctor. Taking it with meals may reduce nausea.

  • Take Deferiprone on a regular schedule to get the most benefit from it.

  • If you also take medicines or supplements that contain iron, aluminum, or zinc (eg, certain antacids), do not take them within at least 4 hours before or after taking Deferiprone. Check with your doctor if you have questions.

  • If you miss a dose of Deferiprone, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Deferiprone.



Important safety information:


  • Deferiprone may lower the ability of your body to fight infection. Avoid contact with people who have colds or infections. Tell your doctor if you notice signs of infection like fever, sore throat, rash, or chills.

  • Deferiprone may discolor the urine a reddish/brown color. This is normal and not a cause for concern.

  • Women who may become pregnant should use an effective form of birth control while taking Deferiprone. Check with your doctor if you have questions about effective birth control.

  • Lab tests, including liver function, blood ferritin and iron levels, blood zinc levels, and complete blood cell counts, may be performed while you take Deferiprone. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Deferiprone should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: Deferiprone may cause harm to the fetus. Do not become pregnant while you are using it. If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of taking Deferiprone while you are pregnant. It is not known if Deferiprone is found in breast milk. Do not breast-feed while taking Deferiprone.


Possible side effects of Deferiprone:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Diarrhea; increased appetite; joint pain; nausea; stomach pain; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); dizziness or light-headedness; fainting; irregular heartbeat; seizures; symptoms of infection (eg, fever, chills, persistent sore throat or cough, flu-like symptoms, difficult or painful urination); unusual bruising.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Deferiprone side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include double vision; slow or abnormal movements; uncontrolled eye movements.


Proper storage of Deferiprone:

Store Deferiprone at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Deferiprone out of the reach of children and away from pets.


General information:


  • If you have any questions about Deferiprone, please talk with your doctor, pharmacist, or other health care provider.

  • Deferiprone is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Deferiprone. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Deferiprone resources


  • Deferiprone Side Effects (in more detail)
  • Deferiprone Use in Pregnancy & Breastfeeding
  • Deferiprone Drug Interactions
  • Deferiprone Support Group
  • 0 Reviews for Deferiprone - Add your own review/rating


  • Deferiprone Professional Patient Advice (Wolters Kluwer)

  • deferiprone Advanced Consumer (Micromedex) - Includes Dosage Information

  • Ferriprox Prescribing Information (FDA)

  • Ferriprox Consumer Overview



Compare Deferiprone with other medications


  • Hemosiderosis

Tuesday 4 May 2010

dihydroergotamine nasal


Generic Name: dihydroergotamine (nasal) (dye HYE droe er GOT a meen)

Brand Names: Migranal


What is dihydroergotamine nasal?

Dihydroergotamine is in a group of drugs called ergot alkaloids (ER-got AL-ka-loids). It works by narrowing the blood vessels around the brain.


Dihydroergotamine nasal is used to a treat migraine headache attack.


This medication will only treat a migraine headache that has already begun. It will not prevent headaches or reduce the number of attacks.


Dihydroergotamine nasal should not be used to treat common tension headaches or any headache that seems to be different from your usual migraine headaches.

Dihydroergotamine nasal may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about dihydroergotamine nasal?


This medication can harm an unborn baby or a nursing baby. Do not use dihydroergotamine nasal if you are pregnant or breast-feeding. Do not use this medication if you are allergic to dihydroergotamine or other ergot medicines, or if you have a history of heart disease, angina (chest pain), blood circulation problems, history of a heart attack or stroke, coronary artery disease, uncontrolled high blood pressure, severe liver or kidney disease, a serious infection, if you have recently had heart or blood vessel surgery. Using certain medications together with dihydroergotamine can cause severe decreases in blood flow and lead to dangerous side effects. Tell your doctor about all other medications you are using, especially antibiotics, antidepressants, heart or blood pressure medications, or medicines to treat HIV or AIDS.

Also tell your doctor about all of your medical conditions, especially breathing problems, high blood pressure, ischemic bowel disease, liver or kidney disease, or risk factors for coronary artery disease (such as diabetes, menopause, smoking, being overweight, having high blood pressure or high cholesterol, having a family history of coronary artery disease, being older than 40 and a man, or being a woman who has had a hysterectomy).


What should I discuss with my healthcare provider before using dihydroergotamine nasal?


Do not use this medication if you are allergic to dihydroergotamine or other ergot medicine such as ergotamine (Ergomar, Ergostat, Cafergot, Ercaf, Wigraine), ergonovine (Ergotrate), methylergonovine (Methergine), or methysergide (Sansert).

Do not use dihydroergotamine nasal if you are pregnant or breast-feeding, or if you have:



  • a history of heart disease, angina (chest pain), blood circulation problems, coronary artery disease (hardening of the arteries), or history of a heart attack or stroke;




  • uncontrolled high blood pressure;



  • severe liver or kidney disease;


  • a serious infection called sepsis; or




  • if you have recently had heart or blood vessel surgery (such as bypass surgery).




Using certain medications together with dihydroergotamine can cause even greater decreases in blood flow than dihydroergotamine used alone. A severe decrease in blood flow to the brain and other parts of the body can lead to dangerous side effects. Do not use dihydroergotamine if you are also using any of the following medications:

  • conivaptan (Vaprisol);




  • diclofenac (Arthrotec, Cataflam, Voltaren, Flector Patch, Solareze);




  • imatinib (Gleevec);




  • isoniazid (for treating tuberculosis);




  • an antibiotic such as clarithromycin (Biaxin), dalfopristin/quinupristin (Synercid), erythromycin (E.E.S., EryPed, Ery-Tab, Erythrocin), telithromycin (Ketek), or troleandomycin (Tao);




  • an antifungal medication such as clotrimazole (Mycelex Troche), itraconazole (Sporanox), ketoconazole (Nizoral), or voriconazole (Vfend);




  • an antidepressant such as nefazodone;




  • heart or blood pressure medication such as diltiazem (Cardizem, Dilacor, Tiazac), nicardipine (Cardene), quinidine (Quinaglute, Quinidex, Quin-Release), or verapamil (Calan, Covera, Isoptin, Verelan); or




  • HIV/AIDS medicine such as amprenavir (Agenerase), atazanavir (Reyataz), delavirdine (Rescriptor), fosamprenavir (Lexiva), indinavir (Crixivan), nelfinavir (Viracept), saquinavir (Invirase, Fortovase), or ritonavir (Norvir).



If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before using dihydroergotamine, tell your doctor if you have:



  • breathing problems;




  • high blood pressure;




  • ischemic bowel disease;




  • liver disease;




  • kidney disease; or




  • coronary artery disease (or risk factors that include diabetes, menopause, smoking, being overweight, having high blood pressure or high cholesterol, having a family history of coronary artery disease, being older than 40 and a man, or being a woman who has had a hysterectomy).




FDA pregnancy category X. This medication can cause birth defects. Do not use dihydroergotamine if you are pregnant. Tell your doctor right away if you become pregnant during treatment. Use an effective form of birth control while you are using this medication. Dihydroergotamine passes into breast milk and may be harmful to a nursing infant. Dihydroergotamine may also decrease milk production. Do not use dihydroergotamine if you are breast-feeding a baby.

How should I use dihydroergotamine nasal?


Use this medication exactly as prescribed by your doctor. Never use more than your prescribed dose of dihydroergotamine nasal. Follow the directions on your prescription label. Tell your doctor if the medicine seems to stop working as well in treating your migraine attacks. Dihydroergotamine is not for daily use.


Dihydroergotamine nasal spray is absorbed quickly through your nasal passages and is for use only in the nose. The nasal spray liquid should not be injected into the body.

Your doctor may want to give your first dose of dihydroergotamine nasal in a hospital or clinic setting to quickly treat any serious side effects that occur.


Dihydroergotamine nasal comes in a bottle (vial) with a nasal sprayer attachment. Do not open the vial and attach the sprayer until you are ready to use the medication. A new vial and sprayer should be used for each new headache episode.


Before using the medication, prime the nasal spray by pumping exactly 4 sprays into the air.


Use the first dose of dihydroergotamine as soon as you notice headache symptoms, or after an attack has already begun. Use one spray in each nostril, and after 15 minutes use a second spray in each nostril, for a total of 4 sprays.


Do not tilt your head back while you are using the nasal spray, and do not sniff through your nose during use or just after use. Throw away the vial and sprayer after you finish using it to treat one headache episode, or no longer than 8 hours after opening the vial.


If you still have migraine symptoms after using a total of 4 sprays, call your doctor before using any more. Do not use more than 6 total sprays of dihydroergotamine nasal in any 24-hour period. Do not use more than 8 total sprays of this medication over a period of 7 days.

If you use dihydroergotamine nasal long-term, your doctor may want to check your heart function periodically using an electrocardiograph or ECG (sometimes called an EKG), a machine that measures electrical activity of the heart. This will help your doctor determine if it is still safe for you to use this medication. Do not miss any scheduled visits to your doctor.


Do not give this medication to anyone else, even if they have the same headache symptoms you have. Dihydroergotamine can be dangerous if it is used to treat headache in a person who has not been diagnosed by a doctor as having true migraine headaches. Store dihydroergotamine nasal at room temperature away from moisture and heat. Do not refrigerate or freeze the nasal spray. Do not use any stored dihydroergotamine if the expiration date on the label has passed.

What happens if I miss a dose?


Since dihydroergotamine is used on an as-needed basis, you are not likely to miss a dose.


Do not use more than 6 sprays of dihydroergotamine nasal per day or more than 8 sprays per week.

What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine. An overdose of dihydroergotamine can be fatal.

Overdose can cause stomach pain, nausea, vomiting, confusion, weak or shallow breathing, numbness and tingling or pain in your hands or feet, blue-colored fingers or toes, fainting, and seizure (convulsions).


What should I avoid while using dihydroergotamine nasal?


Do not use dihydroergotamine nasal within 24 hours before or after using another migraine headache medicine, including:

  • another ergot medicine such as ergotamine (Ergomar, Ergostat, Cafergot, Ercaf, Wigraine), ergonovine (Ergotrate), methylergonovine (Methergine), or methysergide (Sansert); or




  • almotriptan (Axert), eletriptan (Relpax), frovatriptan (Frova), naratriptan (Amerge), sumatriptan (Imitrex), rizatriptan (Maxalt, Maxalt-MLT), or zolmitriptan (Zomig).



Grapefruit and grapefruit juice may interact with dihydroergotamine nasal and lead to potentially dangerous effects. Discuss the use of grapefruit products with your doctor. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor.


Dihydroergotamine nasal side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using dihydroergotamine and call your doctor at once if you have a serious side effect such as:

  • fast or slow heart rate;




  • chest pain or heavy feeling, pain spreading to the arm or shoulder, and nausea, sweating, or general ill feeling;




  • sudden numbness or weakness, sudden headache, confusion, or problems with vision, speech, or balance;




  • muscle pain in your arms or legs, leg weakness;




  • numbness or tingling and a pale or blue-colored appearance in your fingers or toes;




  • swelling or itching in any part of your body;




  • stomach cramps, diarrhea that may be bloody;




  • cough with stabbing chest pain and trouble breathing; or




  • dangerously high blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, confusion, chest pain, shortness of breath, uneven heartbeats, seizure).



Less serious side effects may include:



  • pain, soreness, burning, tingling, or dryness in your nose or throat;




  • runny or stuffy nose, nosebleeds;




  • changes in your sense of taste;




  • headache, dizziness, drowsiness;




  • feeling anxious or depressed;




  • cold sweats; or




  • nausea, vomiting.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


Dihydroergotamine Dosing Information


Usual Adult Dose for Migraine:

IM or subcutaneous: Initial dose: 1 mg given as quickly as possible after the first symptom of headache. Additional 1 mg doses can be given hourly until the headache has stopped or a total dose of 3 mg has been reached. The total weekly dose should not exceed 6 mg.

IV: Initial dose: 1 mg given as quickly as possible after the first symptom of headache. Additional 1 mg doses can be given hourly until the headache has stopped or a total dose of 2 mg has been reached. The total weekly dose should not exceed 6 mg.

Intranasal: 1 spray (0.5 mg) into each nostril (total = 1 mg). Repeat if needed within 15 minutes to a maximum of 4 sprays (2 mg) per day. The total weekly dose should not exceed 8 sprays (4 mg).

Usual Adult Dose for Cluster Headache:

IM or subcutaneous: Initial dose: 1 mg given as quickly as possible after the first symptom of headache. Additional 1 mg doses can be given hourly until the headache has stopped or a total dose of 3 mg has been reached. The total weekly dose should not exceed 6 mg.

IV: Initial dose: 1 mg given as quickly as possible after the first symptom of headache. Additional 1 mg doses can be given hourly until the headache has stopped or a total dose of 2 mg has been reached. The total weekly dose should not exceed 6 mg.


What other drugs will affect dihydroergotamine nasal?


Many drugs can interact with dihydroergotamine. Below is just a partial list. Talk with your doctor before using dihydroergotamine nasal if you are also taking:



  • zileuton (Zyflo);




  • cold or allergy medications;




  • nicotine (Nicoderm, Nicorette);




  • diet pills, stimulants, or medication to treat ADHD (such as Ritalin or Adderall);




  • an antidepressant such as fluoxetine (Prozac, Sarafem), fluvoxamine (Luvox), nefazodone (Serzone), paroxetine (Paxil), sertraline (Zoloft), and others; or




  • heart or blood pressure medication such as atenolol (Tenormin), carvedilol (Coreg), labetalol (Normodyne, Trandate), metoprolol (Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal, InnoPran), sotalol (Betapace), and others.



This list is not complete and there may be other drugs that can interact with dihydroergotamine. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More dihydroergotamine resources


  • Dihydroergotamine Side Effects (in more detail)
  • Dihydroergotamine Use in Pregnancy & Breastfeeding
  • Dihydroergotamine Drug Interactions
  • Dihydroergotamine Support Group
  • 12 Reviews for Dihydroergotamine - Add your own review/rating


Compare dihydroergotamine with other medications


  • Cluster Headaches
  • Migraine


Where can I get more information?


  • Your pharmacist can provide more information about dihydroergotamine nasal.

See also: dihydroergotamine side effects (in more detail)


Monday 3 May 2010

Glibenclamide Sopharma




Glibenclamide Sopharma may be available in the countries listed below.


Ingredient matches for Glibenclamide Sopharma



Glibenclamide

Glibenclamide is reported as an ingredient of Glibenclamide Sopharma in the following countries:


  • Bulgaria

International Drug Name Search